A significant clinical study sponsored by Harokopio University, alongside the National and Kapodistrian University of Athens and the University of Belgrade, is shedding light on the effects of creatine monohydrate on breath-hold cycling performance. This targeted research evaluates the impact of a 7-day creatine loading intervention among healthy participants.
In this article:
- What is the focus of this study?
- What is the study’s methodology?
- What outcomes are anticipated?
- FAQs
- Conclusion and actionable insights
- Professional disclaimer
- Access the official record
What is the focus of this study?
The clinical trial investigates the physiological effects of creatine monohydrate loading on athletes or individuals participating in breath-hold cycling activities. The study aims to determine whether this dietary intervention improves cycling performance under hypoxic conditions. Results could provide evidence supporting its use in both sports performance and broader physiologic adaptations.
What is the study’s methodology?
The study involves healthy participants under a controlled trial design. Two distinct arms were established: one group is given creatine monohydrate as a dietary supplement, and the other group receives a placebo. The controlled intake spans seven days. Researchers assess respiratory, muscular, and endurance parameters to measure performance improvements.
This trial employs rigorous scientific protocols, including monitoring dietary compliance and collecting objective physiological metrics. The controlled setting ensures unbiased and reproducible results.
What outcomes are anticipated?
The anticipated results of this trial include improved breath-hold times, enhanced anaerobic capacity, and better recovery post-effort in the creatine group compared to the placebo. These outcomes will be benchmarked against the performance variables measured throughout the trial.
Despite preliminary enthusiasm, it is crucial to note that no formal conclusions are drawn until data is fully analyzed and peer-reviewed. Professionals and stakeholders are encouraged to await the trial’s completion for conclusive insights.
FAQs
- Who qualifies for this study? This study is currently enrolling by invitation only and focuses on healthy individuals meeting specific inclusion criteria.
- What is creatine monohydrate? It is a popular dietary supplement known for improving athletic performance, generally by enhancing energy production in muscle cells.
- What makes breath-hold cycling unique? It combines hypoxic endurance with anaerobic thresholds, making it a challenging and relevant test of physical performance.
Conclusion and actionable insights
This study represents an important intersection of dietary supplementation and performance physiology. If creatine monohydrate proves beneficial, its practical applications could extend beyond professional athletics into other fields such as clinical rehabilitation and extreme environment training.
Professional disclaimer
This content is intended for healthcare providers, clinical researchers, and regulatory teams. It does not constitute legal or clinical advice. For specific recommendations, consult a qualified professional.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07233707?term=medical+device